Ended 2024 with $71.1 million of cash and cash equivalents and no debtConference Call and Webcast Scheduled for Tuesday, March 25, 2025, at 8:30 ...

Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) will likely be posting its quarterly earnings results on Tuesday, March ...

All listeners should provide the operator with the conference call name "Atossa Therapeutics Business Update" to join. Following the conclusion of the conference call, a replay will be available for ...

Atossa Therapeutics (NASDAQ:ATOS – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a report released on Wednesday,Benzinga reports. They currently have a ...

Atossa Therapeutics, Inc. announced its decision to pursue a metastatic breast cancer indication for (Z)-endoxifen, a selective estrogen receptor modulator (SERM) that has demonstrated encouraging ...

The connection between sugar and cancer, including whether you need to give up your favorite sweet bites to stave off cancer.

SEATTLE, March 20, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company ...

These seven high-quality ETFs provide current income and offer the opportunity for growth over time.

SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of ...